MedTrace Logo

Post-Procedural Biotech Cellulose Mask

NCT06065332 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-10-03

No results posted yet for this study

Summary

Background: There are many post-procedural treatments touted to improve comfort and decrease downtime, but very few prospective randomized studies.

Aims: To analyze the safety and efficacy of a post-procedural biotech cellulose mask Patients/Method: Fifteen patients undergoing either a microneedling with radiofrequency (n=5), non-ablative fractional (n=5), or full erbium;YAG resurfacing (n=5) treatment were randomized to receive a Velez biotech cellulose mask on one side of the face for 30 minutes after the procedure and for two hours a day until healed. Canfield Visia photos and thermal photographs were taken 30 minutes after the procedure and daily until healed. The investigator and blind evaluators reviewed the photos and subjects answered daily questionnaires.

Conditions

  • Temperature Change, Body

Interventions

OTHER

Velez Intense Hydration Mask® (biotech cellulose face mask)

Application to one randomized side half of a Velez Intense Hydration Mask® (biotech cellulose face mask)

Sponsors & Collaborators

  • Siperstein Dermatology

    lead OTHER

Principal Investigators

  • Robyn D Siperstein, MD · Siperstein Dermatology Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-07
Primary Completion
2022-12-09
Completion
2023-03-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06065332 on ClinicalTrials.gov